Home > Press Releases > Chronic Disease Management Market

Chronic Disease Management Market Likely to Surpass ~USD 16 billion by 2035

Report Code: HC-56541  |  Published in: Apr 2026, By MarketGenics  |  Number of pages: 287
Get PDF
Buy

Global Chronic Disease Management Market Forecast 2035:

According to the report, the global chronic disease management market is likely to grow from USD 5.8 Billion in 2025 to USD 16.1 Billion in 2035 at a highest CAGR of 10.8% during the time period. Chronic disease management market continues to grow quickly because of the increases in cases of these diseases, more awareness of patients about their diseases, and an increase in patients using digital health technology. Providers are using tools for remote monitoring of patients, such as remote monitoring devices, mobile health apps, and telehealth services to help provider’s track vitals and adhere to medication regimens, and provide individualized care.

Additionally, various government incentives geared towards preventing disease and moving more providers towards value-based models are encouraging usage of chronic disease management throughout developing countries. Further, improved integration between traditional healthcare technologies with newer technologies utilizing artificial intelligence (AI), machine learning (ML), and predictive analytics will improve accurate and timely identification of chronic disease (early) and improve individual patient treatment plans (personal), and provide an opportunity for continuous health monitoring of patients suffering from chronic conditions such as diabetes, cardiovascular, and respiratory diseases.

Moreover, the continued use of mobile and app-based digital therapeutic products will help to allow for real time tracking of patients’ health while improving patient engagement and creating new opportunities for providers to see the patient and use their electronic health records, and for insurers to assist the patient with paying for their healthcare costs.

Key Driver, Restraint, and Growth Opportunity Shaping the Global Chronic disease management Market

The global chronic disease management market has experienced growth because pharmacies and retail clinics and telehealth services now use digital platforms to enhance patient monitoring and medication adherence and deliver customized treatment recommendations. The system enables better operational performance through its capacity to track vital signs and deliver reminders and connect with data obtained from wearable devices because more patients choose to monitor their health and practice self-care in their homes.

For instance, Omron Healthcare launched its Connected Health Hub in 2025 to enable blood pressure and heart rate monitoring through AI-based insights which help patients manage their health.

The main obstacle requires organizations to maintain data correctness while establishing seamless data exchange between various sources which include wearable technology and electronic health records (EHRs) and mobile applications. Digital chronic care solutions face scalability and efficiency constraints because device calibration errors and missing patient data and outdated EHR systems need staff members to perform manual reconciliation.

The field of digital therapeutics and remote monitoring displays strong potential for use in preventive healthcare to treat diabetes and hypertension and cardiovascular diseases. The AI-powered diabetes program from Livongo (2025) proves that continuous data collection together with customized coaching and cloud analytics achieves better patient engagement and adherence while enabling early intervention which makes chronic care more available to patients around the world.

Expansion of Global Chronic Disease Management Market

Digital Health Solutions, Preventive Care, and Healthcare Infrastructure Investments Driving the Global Chronic Disease Management Market Expansion

  • The global chronic disease management market is experiencing strong growth because digital health solutions have become standard, preventive care has gained more focus, and the healthcare sector has received major funding for its infrastructure development. Digital health technologies that include remote patient monitoring devices and wearable sensors and AI-driven analytics and mobile health applications enable constant monitoring of vital signs together with customized treatment plans and immediate patient interaction.
  • For example, Omron Healthcare introduced its Connected Health Hub in 2025 with AI-enabled blood pressure and heart rate monitoring functions that help patients and doctors better handle their chronic conditions. Livongo expanded its diabetes management platform to include predictive alerts together with electronic health record integration which demonstrates how digital therapeutics improve patient-centered healthcare.
  • Preventive healthcare initiatives are also fueling market growth as governments and healthcare providers focus on early detection and lifestyle interventions and value-based care models which help reduce hospitalizations and decrease long-term expenses. The U.S. National Diabetes Prevention Program and similar programs have driven progress for established digital care solutions which target high-risk groups.
  • The healthcare infrastructure investments which support cloud-based EHR systems and telehealth networks and interoperable platforms. The global chronic disease management market expands because of technological innovation and preventive care and infrastructure development which results in better efficiency and patient engagement and improved healthcare system performance.

Regional Analysis of Global Chronic Disease Management Market

  • North America leads global chronic disease management because it has advanced healthcare systems and high rates of chronic diseases and established payment systems. The CDC reports that approximately 60 percent of American adults suffer from at least one chronic illness which requires ongoing medical treatment thus leading to the widespread use of remote patient monitoring and telehealth systems.
  • The availability of telehealth services through Medicare and private insurance makes it easier for people to access digital healthcare solutions. North America dominates the market because it has numerous healthcare technology companies that make significant investments in AI-based disease management systems and telemedicine services. The CareConnect AI Platform developed by Epic Systems Corporation in 2025 enables hospitals and clinics to use its AI system for remote patient monitoring and predictive analytics in chronic disease management.
  • The Asia Pacific region leads as the most rapidly expanding area for chronic disease management because healthcare systems digitize more and people learn about preventive healthcare and medical services extend into rural communities. The countries of India and China show rapid growth in their use of mobile health applications which people use on their smartphones and wearable devices and AI-based digital medical treatments.
  • The Ayushman Bharat Digital Mission in India has enabled millions of patients to access telehealth and remote chronic care services. The region will experience double-digit growth because domestic startups will increase their investments and collaborate with international digital health companies, making Asia Pacific the main driver of worldwide market growth for chronic disease management.

Prominent players operating in global chronic disease management market include prominent companies such as Allscripts Healthcare Solutions, Inc., Altruista Health, Inc., BioTelemetry, Inc., Cognizant Technology Solutions Corporation, Epic Systems Corporation, GE HealthCare Technologies Inc., Health Catalyst, Inc., IBM Corporation, iHealth Labs, Inc., Infosys Limited, Koninklijke Philips N.V., Medtronic plc, Omada Health, Inc., Oracle Health (Cerner Corporation), Pegasystems Inc., Siemens Healthineers AG, Teladoc Health, Inc., TriZetto Corporation, WellDoc, Inc., ZeOmega, Inc., along with several other key players.

The global chronic disease management market has been segmented as follows:

Global Chronic Disease Management Market Analysis, by Component

  • Solutions (Software & Platforms)
    • Care Management Software
    • Disease Management Platforms
    • Remote Patient Monitoring (RPM) Software
    • Patient Engagement & Communication Platforms
    • Clinical Decision Support Systems (CDSS)
    • Population Health Management (PHM) Software
    • Mobile Health (mHealth) Applications
    • Telehealth & Telemedicine Platforms
    • EHR/EMR Integration Modules
    • Data Analytics & Predictive Modeling Tools
    • Workflow & Care Coordination Software
    • Medication Management Software
    • Others
  • Services
    • Consulting Services
    • Implementation & Integration Services
    • Training & Education Services
    • Managed Disease Management Services
    • Remote Monitoring Services
    • Telehealth Services
    • Health Coaching & Wellness Services
    • Data Management & Analytics Services
    • Technical Support & Maintenance Services
    • Care Coordination Services
    • Others

Global Chronic Disease Management Market Analysis, by Deployment Mode

  • On-Premises
  • Cloud
  • Hybrid

Global Chronic Disease Management Market Analysis, by Disease Type

  • Cardiovascular Diseases
  • Diabetes
  • Chronic Respiratory Diseases
  • Cancer
  • Arthritis & Musculoskeletal Disorders
  • Neurological Disorders
  • Chronic Kidney Disease
  • Mental Health Disorders
  • Others

Global Chronic Disease Management Market Analysis, by Technology

  • Artificial Intelligence (AI) & Machine Learning
  • Internet of Things (IoT)
  • Wearable Devices
  • Mobile Health (mHealth)
  • Telehealth Technologies
  • Big Data Analytics
  • Cloud Computing
  • Digital Therapeutics
  • Others

Global Chronic Disease Management Market Analysis, by Delivery Model

  • Provider-Based Models
  • Payer-Based Models
  • Value-Based Care Models
  • Integrated Care Models
  • Home-Based Care Models
  • Community-Based Programs
  • Preventive Care Models
  • Personalized Care Models
  • Others

Global Chronic Disease Management Market Analysis, by Application

  • Disease Monitoring & Tracking
  • Medication Management
  • Care Coordination
  • Patient Engagement & Education
  • Lifestyle & Wellness Management
  • Remote Patient Monitoring
  • Clinical Decision Support
  • Post-Acute Care Management
  • Others

Global Chronic Disease Management Market Analysis, by End User

  • Hospitals & Clinics
  • Healthcare Payers
  • Home Healthcare Providers
  • Employers & Corporate Wellness Programs
  • Specialty Care Centers
  • Long-Term Care Facilities
  • Pharmacies & Retail Clinics
  • Patients / Individuals
  • Others

Global Chronic Disease Management Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Natures
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Natures
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Chronic Disease Management Market Outlook
      • 2.1.1. Chronic Disease Management Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of chronic diseases and growing patient awareness of self-management.
        • 4.1.1.2. Increasing adoption of digital health solutions, including remote monitoring, AI, and telehealth platforms.
        • 4.1.1.3. Government initiatives and healthcare infrastructure investments promoting preventive and value-based care.
      • 4.1.2. Restraints
        • 4.1.2.1. Data privacy concerns and stringent regulatory compliance requirements limiting rapid digital adoption.
        • 4.1.2.2. High implementation costs and integration challenges with legacy healthcare IT systems.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Chronic Disease Management Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Chronic Disease Management Market Analysis, by Component
    • 6.1. Key Segment Analysis
    • 6.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
      • 6.2.1. Solutions (Software & Platforms)
        • 6.2.1.1. Care Management Software
        • 6.2.1.2. Disease Management Platforms
        • 6.2.1.3. Remote Patient Monitoring (RPM) Software
        • 6.2.1.4. Patient Engagement & Communication Platforms
        • 6.2.1.5. Clinical Decision Support Systems (CDSS)
        • 6.2.1.6. Population Health Management (PHM) Software
        • 6.2.1.7. Mobile Health (mHealth) Applications
        • 6.2.1.8. Telehealth & Telemedicine Platforms
        • 6.2.1.9. EHR/EMR Integration Modules
        • 6.2.1.10. Data Analytics & Predictive Modeling Tools
        • 6.2.1.11. Workflow & Care Coordination Software
        • 6.2.1.12. Medication Management Software
        • 6.2.1.13. Others
      • 6.2.2. Services
        • 6.2.2.1. Consulting Services
        • 6.2.2.2. Implementation & Integration Services
        • 6.2.2.3. Training & Education Services
        • 6.2.2.4. Managed Disease Management Services
        • 6.2.2.5. Remote Monitoring Services
        • 6.2.2.6. Telehealth Services
        • 6.2.2.7. Health Coaching & Wellness Services
        • 6.2.2.8. Data Management & Analytics Services
        • 6.2.2.9. Technical Support & Maintenance Services
        • 6.2.2.10. Care Coordination Services
        • 6.2.2.11. Others
  • 7. Global Chronic Disease Management Market Analysis, by Deployment Mode
    • 7.1. Key Segment Analysis
    • 7.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 7.2.1. On-Premises
      • 7.2.2. Cloud
      • 7.2.3. Hybrid
  • 8. Global Chronic Disease Management Market Analysis, by Disease Type
    • 8.1. Key Segment Analysis
    • 8.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Disease Type, 2021-2035
      • 8.2.1. Cardiovascular Diseases
      • 8.2.2. Diabetes
      • 8.2.3. Chronic Respiratory Diseases
      • 8.2.4. Cancer
      • 8.2.5. Arthritis & Musculoskeletal Disorders
      • 8.2.6. Neurological Disorders
      • 8.2.7. Chronic Kidney Disease
      • 8.2.8. Mental Health Disorders
      • 8.2.9. Others
  • 9. Global Chronic Disease Management Market Analysis, by Technology
    • 9.1. Key Segment Analysis
    • 9.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 9.2.1. Artificial Intelligence (AI) & Machine Learning
      • 9.2.2. Internet of Things (IoT)
      • 9.2.3. Wearable Devices
      • 9.2.4. Mobile Health (mHealth)
      • 9.2.5. Telehealth Technologies
      • 9.2.6. Big Data Analytics
      • 9.2.7. Cloud Computing
      • 9.2.8. Digital Therapeutics
      • 9.2.9. Others
  • 10. Global Chronic Disease Management Market Analysis, by Delivery Model
    • 10.1. Key Segment Analysis
    • 10.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Delivery Model, 2021-2035
      • 10.2.1. Provider-Based Models
      • 10.2.2. Payer-Based Models
      • 10.2.3. Value-Based Care Models
      • 10.2.4. Integrated Care Models
      • 10.2.5. Home-Based Care Models
      • 10.2.6. Community-Based Programs
      • 10.2.7. Preventive Care Models
      • 10.2.8. Personalized Care Models
      • 10.2.9. Others
  • 11. Global Chronic Disease Management Market Analysis, by Application
    • 11.1. Key Segment Analysis
    • 11.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 11.2.1. Disease Monitoring & Tracking
      • 11.2.2. Medication Management
      • 11.2.3. Care Coordination
      • 11.2.4. Patient Engagement & Education
      • 11.2.5. Lifestyle & Wellness Management
      • 11.2.6. Remote Patient Monitoring
      • 11.2.7. Clinical Decision Support
      • 11.2.8. Post-Acute Care Management
      • 11.2.9. Others
  • 12. Global Chronic Disease Management Market Analysis, by End User
    • 12.1. Key Segment Analysis
    • 12.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 12.2.1. Hospitals & Clinics
      • 12.2.2. Healthcare Payers
      • 12.2.3. Home Healthcare Providers
      • 12.2.4. Employers & Corporate Wellness Programs
      • 12.2.5. Specialty Care Centers
      • 12.2.6. Long-Term Care Facilities
      • 12.2.7. Pharmacies & Retail Clinics
      • 12.2.8. Patients / Individuals
      • 12.2.9. Others
  • 13. Global Chronic Disease Management Market Analysis and Forecasts, by Region
    • 13.1. Key Findings
    • 13.2. Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 13.2.1. North America
      • 13.2.2. Europe
      • 13.2.3. Asia Pacific
      • 13.2.4. Middle East
      • 13.2.5. Africa
      • 13.2.6. South America
  • 14. North America Chronic Disease Management Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. North America Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Component
      • 14.3.2. Deployment Mode
      • 14.3.3. Disease Type
      • 14.3.4. Technology
      • 14.3.5. Delivery Model
      • 14.3.6. Application
      • 14.3.7. End User
      • 14.3.8. Country
        • 14.3.8.1. USA
        • 14.3.8.2. Canada
        • 14.3.8.3. Mexico
    • 14.4. USA Chronic Disease Management Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Component
      • 14.4.3. Deployment Mode
      • 14.4.4. Disease Type
      • 14.4.5. Technology
      • 14.4.6. Delivery Model
      • 14.4.7. Application
      • 14.4.8. End User
    • 14.5. Canada Chronic Disease Management Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Component
      • 14.5.3. Deployment Mode
      • 14.5.4. Disease Type
      • 14.5.5. Technology
      • 14.5.6. Delivery Model
      • 14.5.7. Application
      • 14.5.8. End User
    • 14.6. Mexico Chronic Disease Management Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Component
      • 14.6.3. Deployment Mode
      • 14.6.4. Disease Type
      • 14.6.5. Technology
      • 14.6.6. Delivery Model
      • 14.6.7. Application
      • 14.6.8. End User
  • 15. Europe Chronic Disease Management Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Europe Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Component
      • 15.3.2. Deployment Mode
      • 15.3.3. Disease Type
      • 15.3.4. Technology
      • 15.3.5. Delivery Model
      • 15.3.6. Application
      • 15.3.7. End User
      • 15.3.8. Country
        • 15.3.8.1. Germany
        • 15.3.8.2. United Kingdom
        • 15.3.8.3. France
        • 15.3.8.4. Italy
        • 15.3.8.5. Spain
        • 15.3.8.6. Netherlands
        • 15.3.8.7. Nordic Countries
        • 15.3.8.8. Poland
        • 15.3.8.9. Russia & CIS
        • 15.3.8.10. Rest of Europe
    • 15.4. Germany Chronic Disease Management Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Component
      • 15.4.3. Deployment Mode
      • 15.4.4. Disease Type
      • 15.4.5. Technology
      • 15.4.6. Delivery Model
      • 15.4.7. Application
      • 15.4.8. End User
    • 15.5. United Kingdom Chronic Disease Management Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Component
      • 15.5.3. Deployment Mode
      • 15.5.4. Disease Type
      • 15.5.5. Technology
      • 15.5.6. Delivery Model
      • 15.5.7. Application
      • 15.5.8. End User
    • 15.6. France Chronic Disease Management Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Component
      • 15.6.3. Deployment Mode
      • 15.6.4. Disease Type
      • 15.6.5. Technology
      • 15.6.6. Delivery Model
      • 15.6.7. Application
      • 15.6.8. End User
    • 15.7. Italy Chronic Disease Management Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Component
      • 15.7.3. Deployment Mode
      • 15.7.4. Disease Type
      • 15.7.5. Technology
      • 15.7.6. Delivery Model
      • 15.7.7. Application
      • 15.7.8. End User
    • 15.8. Spain Chronic Disease Management Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Component
      • 15.8.3. Deployment Mode
      • 15.8.4. Disease Type
      • 15.8.5. Technology
      • 15.8.6. Delivery Model
      • 15.8.7. Application
      • 15.8.8. End User
    • 15.9. Netherlands Chronic Disease Management Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Component
      • 15.9.3. Deployment Mode
      • 15.9.4. Disease Type
      • 15.9.5. Technology
      • 15.9.6. Delivery Model
      • 15.9.7. Application
      • 15.9.8. End User
    • 15.10. Nordic Countries Chronic Disease Management Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Component
      • 15.10.3. Deployment Mode
      • 15.10.4. Disease Type
      • 15.10.5. Technology
      • 15.10.6. Delivery Model
      • 15.10.7. Application
      • 15.10.8. End User
    • 15.11. Poland Chronic Disease Management Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Component
      • 15.11.3. Deployment Mode
      • 15.11.4. Disease Type
      • 15.11.5. Technology
      • 15.11.6. Delivery Model
      • 15.11.7. Application
      • 15.11.8. End User
    • 15.12. Russia & CIS Chronic Disease Management Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Component
      • 15.12.3. Deployment Mode
      • 15.12.4. Disease Type
      • 15.12.5. Technology
      • 15.12.6. Delivery Model
      • 15.12.7. Application
      • 15.12.8. End User
    • 15.13. Rest of Europe Chronic Disease Management Market
      • 15.13.1. Country Segmental Analysis
      • 15.13.2. Component
      • 15.13.3. Deployment Mode
      • 15.13.4. Disease Type
      • 15.13.5. Technology
      • 15.13.6. Delivery Model
      • 15.13.7. Application
      • 15.13.8. End User
  • 16. Asia Pacific Chronic Disease Management Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Asia Pacific Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Component
      • 16.3.2. Deployment Mode
      • 16.3.3. Disease Type
      • 16.3.4. Technology
      • 16.3.5. Delivery Model
      • 16.3.6. Application
      • 16.3.7. End User
      • 16.3.8. Country
        • 16.3.8.1. China
        • 16.3.8.2. India
        • 16.3.8.3. Japan
        • 16.3.8.4. South Korea
        • 16.3.8.5. Australia and New Zealand
        • 16.3.8.6. Indonesia
        • 16.3.8.7. Malaysia
        • 16.3.8.8. Thailand
        • 16.3.8.9. Vietnam
        • 16.3.8.10. Rest of Asia Pacific
    • 16.4. China Chronic Disease Management Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Component
      • 16.4.3. Deployment Mode
      • 16.4.4. Disease Type
      • 16.4.5. Technology
      • 16.4.6. Delivery Model
      • 16.4.7. Application
      • 16.4.8. End User
    • 16.5. India Chronic Disease Management Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Component
      • 16.5.3. Deployment Mode
      • 16.5.4. Disease Type
      • 16.5.5. Technology
      • 16.5.6. Delivery Model
      • 16.5.7. Application
      • 16.5.8. End User
    • 16.6. Japan Chronic Disease Management Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Component
      • 16.6.3. Deployment Mode
      • 16.6.4. Disease Type
      • 16.6.5. Technology
      • 16.6.6. Delivery Model
      • 16.6.7. Application
      • 16.6.8. End User
    • 16.7. South Korea Chronic Disease Management Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Component
      • 16.7.3. Deployment Mode
      • 16.7.4. Disease Type
      • 16.7.5. Technology
      • 16.7.6. Delivery Model
      • 16.7.7. Application
      • 16.7.8. End User
    • 16.8. Australia and New Zealand Chronic Disease Management Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Component
      • 16.8.3. Deployment Mode
      • 16.8.4. Disease Type
      • 16.8.5. Technology
      • 16.8.6. Delivery Model
      • 16.8.7. Application
      • 16.8.8. End User
    • 16.9. Indonesia Chronic Disease Management Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Component
      • 16.9.3. Deployment Mode
      • 16.9.4. Disease Type
      • 16.9.5. Technology
      • 16.9.6. Delivery Model
      • 16.9.7. Application
      • 16.9.8. End User
    • 16.10. Malaysia Chronic Disease Management Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Component
      • 16.10.3. Deployment Mode
      • 16.10.4. Disease Type
      • 16.10.5. Technology
      • 16.10.6. Delivery Model
      • 16.10.7. Application
      • 16.10.8. End User
    • 16.11. Thailand Chronic Disease Management Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Component
      • 16.11.3. Deployment Mode
      • 16.11.4. Disease Type
      • 16.11.5. Technology
      • 16.11.6. Delivery Model
      • 16.11.7. Application
      • 16.11.8. End User
    • 16.12. Vietnam Chronic Disease Management Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Component
      • 16.12.3. Deployment Mode
      • 16.12.4. Disease Type
      • 16.12.5. Technology
      • 16.12.6. Delivery Model
      • 16.12.7. Application
      • 16.12.8. End User
    • 16.13. Rest of Asia Pacific Chronic Disease Management Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Component
      • 16.13.3. Deployment Mode
      • 16.13.4. Disease Type
      • 16.13.5. Technology
      • 16.13.6. Delivery Model
      • 16.13.7. Application
      • 16.13.8. End User
  • 17. Middle East Chronic Disease Management Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Middle East Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Component
      • 17.3.2. Deployment Mode
      • 17.3.3. Disease Type
      • 17.3.4. Technology
      • 17.3.5. Delivery Model
      • 17.3.6. Application
      • 17.3.7. End User
      • 17.3.8. Country
        • 17.3.8.1. Turkey
        • 17.3.8.2. UAE
        • 17.3.8.3. Saudi Arabia
        • 17.3.8.4. Israel
        • 17.3.8.5. Rest of Middle East
    • 17.4. Turkey Chronic Disease Management Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Component
      • 17.4.3. Deployment Mode
      • 17.4.4. Disease Type
      • 17.4.5. Technology
      • 17.4.6. Delivery Model
      • 17.4.7. Application
      • 17.4.8. End User
    • 17.5. UAE Chronic Disease Management Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Component
      • 17.5.3. Deployment Mode
      • 17.5.4. Disease Type
      • 17.5.5. Technology
      • 17.5.6. Delivery Model
      • 17.5.7. Application
      • 17.5.8. End User
    • 17.6. Saudi Arabia Chronic Disease Management Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Component
      • 17.6.3. Deployment Mode
      • 17.6.4. Disease Type
      • 17.6.5. Technology
      • 17.6.6. Delivery Model
      • 17.6.7. Application
      • 17.6.8. End User
    • 17.7. Israel Chronic Disease Management Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Component
      • 17.7.3. Deployment Mode
      • 17.7.4. Disease Type
      • 17.7.5. Technology
      • 17.7.6. Delivery Model
      • 17.7.7. Application
      • 17.7.8. End User
    • 17.8. Rest of Middle East Chronic Disease Management Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Component
      • 17.8.3. Deployment Mode
      • 17.8.4. Disease Type
      • 17.8.5. Technology
      • 17.8.6. Delivery Model
      • 17.8.7. Application
      • 17.8.8. End User
  • 18. Africa Chronic Disease Management Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Africa Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Component
      • 18.3.2. Deployment Mode
      • 18.3.3. Disease Type
      • 18.3.4. Technology
      • 18.3.5. Delivery Model
      • 18.3.6. Application
      • 18.3.7. End User
      • 18.3.8. Country
        • 18.3.8.1. South Africa
        • 18.3.8.2. Egypt
        • 18.3.8.3. Nigeria
        • 18.3.8.4. Algeria
        • 18.3.8.5. Rest of Africa
    • 18.4. South Africa Chronic Disease Management Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Component
      • 18.4.3. Deployment Mode
      • 18.4.4. Disease Type
      • 18.4.5. Technology
      • 18.4.6. Delivery Model
      • 18.4.7. Application
      • 18.4.8. End User
    • 18.5. Egypt Chronic Disease Management Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Component
      • 18.5.3. Deployment Mode
      • 18.5.4. Disease Type
      • 18.5.5. Technology
      • 18.5.6. Delivery Model
      • 18.5.7. Application
      • 18.5.8. End User
    • 18.6. Nigeria Chronic Disease Management Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Component
      • 18.6.3. Deployment Mode
      • 18.6.4. Disease Type
      • 18.6.5. Technology
      • 18.6.6. Delivery Model
      • 18.6.7. Application
      • 18.6.8. End User
    • 18.7. Algeria Chronic Disease Management Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Component
      • 18.7.3. Deployment Mode
      • 18.7.4. Disease Type
      • 18.7.5. Technology
      • 18.7.6. Delivery Model
      • 18.7.7. Application
      • 18.7.8. End User
    • 18.8. Rest of Africa Chronic Disease Management Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Component
      • 18.8.3. Deployment Mode
      • 18.8.4. Disease Type
      • 18.8.5. Technology
      • 18.8.6. Delivery Model
      • 18.8.7. Application
      • 18.8.8. End User
  • 19. South America Chronic Disease Management Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. South America Chronic Disease Management Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Component
      • 19.3.2. Deployment Mode
      • 19.3.3. Disease Type
      • 19.3.4. Technology
      • 19.3.5. Delivery Model
      • 19.3.6. Application
      • 19.3.7. End User
      • 19.3.8. Country
        • 19.3.8.1. Brazil
        • 19.3.8.2. Argentina
        • 19.3.8.3. Rest of South America
    • 19.4. Brazil Chronic Disease Management Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Component
      • 19.4.3. Deployment Mode
      • 19.4.4. Disease Type
      • 19.4.5. Technology
      • 19.4.6. Delivery Model
      • 19.4.7. Application
      • 19.4.8. End User
    • 19.5. Argentina Chronic Disease Management Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Component
      • 19.5.3. Deployment Mode
      • 19.5.4. Disease Type
      • 19.5.5. Technology
      • 19.5.6. Delivery Model
      • 19.5.7. Application
      • 19.5.8. End User
    • 19.6. Rest of South America Chronic Disease Management Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Component
      • 19.6.3. Deployment Mode
      • 19.6.4. Disease Type
      • 19.6.5. Technology
      • 19.6.6. Delivery Model
      • 19.6.7. Application
      • 19.6.8. End User
  • 20. Key Players/ Company Profile
    • 20.1. Allscripts Healthcare Solutions, Inc.
      • 20.1.1. Company Details/ Overview
      • 20.1.2. Company Financials
      • 20.1.3. Key Customers and Competitors
      • 20.1.4. Business/ Industry Portfolio
      • 20.1.5. Product Portfolio/ Specification Details
      • 20.1.6. Pricing Data
      • 20.1.7. Strategic Overview
      • 20.1.8. Recent Developments
    • 20.2. Altruista Health, Inc.
    • 20.3. BioTelemetry, Inc.
    • 20.4. Cognizant Technology Solutions Corporation
    • 20.5. Epic Systems Corporation
    • 20.6. GE HealthCare Technologies Inc.
    • 20.7. Health Catalyst, Inc.
    • 20.8. IBM Corporation
    • 20.9. iHealth Labs, Inc.
    • 20.10. Infosys Limited
    • 20.11. Koninklijke Philips N.V.
    • 20.12. Medtronic plc
    • 20.13. Omada Health, Inc.
    • 20.14. Oracle Health (Cerner Corporation)
    • 20.15. Pegasystems Inc.
    • 20.16. Siemens Healthineers AG
    • 20.17. Teladoc Health, Inc.
    • 20.18. TriZetto Corporation
    • 20.19. WellDoc, Inc.
    • 20.20. ZeOmega, Inc.
    • 20.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation